These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12034192)

  • 1. Prevention of cytomegalovirus infection and disease in high-risk renal transplant recipients with polyvalent intravenous immunoglobulins.
    Séchet A; Bridoux F; Bauwens M; Ayache RA; Belmouaz S; Touchard G
    Transplant Proc; 2002 May; 34(3):812-3. PubMed ID: 12034192
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New immunosuppressive regimens and cytomegalovirus infection after kidney transplantation: a retrospective study.
    Côté I; Deschêsnes L; de Cotret PR; Lachance JG; Noël R; Isenring P; Houde I
    Transplant Proc; 2001; 33(7-8):3626-9. PubMed ID: 11750540
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin.
    Valantine HA
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):49-57. PubMed ID: 7482821
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective strategies to prevent cytomegalovirus disease after renal transplantation.
    Chapman JR
    Transplant Proc; 2000 Nov; 32(7):1508-9. PubMed ID: 11119809
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient.
    Uber L; Cofer J; Baliga P; Rajagopalan PR
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):42-3. PubMed ID: 7482818
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus infection in marrow transplantation.
    Boeckh M; Bowden R
    Cancer Treat Res; 1995; 76():97-136. PubMed ID: 7577347
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A; Dykeman-Sharpe J
    CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients.
    Chak WL; Choi KS; Wong KM; Chan YH; Chau KF; Li CS
    Transplant Proc; 2003 Feb; 35(1):280-1. PubMed ID: 12591399
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease.
    Conti DJ; Freed BM; Lempert N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1421-2. PubMed ID: 8382867
    [No Abstract]   [Full Text] [Related]  

  • 11. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic cytomegalovirus management strategies.
    Martin M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):23-7. PubMed ID: 7482812
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients.
    Flynn JT; Kaiser BA; Long SS; Schulman SL; Deforest A; Polinsky MS; Baluarte HJ
    Am J Nephrol; 1997; 17(2):146-52. PubMed ID: 9096445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease.
    Waiser J; Budde K; Schreiber M; Korn K; Stenglein S; Drenckhahn JT; Böhler T; Hauser I; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2083-5. PubMed ID: 9723399
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing incidence of cytomegalovirus disease in Indian renal transplant recipients on cyclosporine immunosuppression.
    Sakhuja V; Jha V; Joshi K; Nada R; Sud K; Kohli HS; Gupta KL; Sehgal S
    Transplant Proc; 2001; 33(7-8):3631-2. PubMed ID: 11750542
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and treatment of cytomegalovirus infection after renal transplantation.
    Guandelin M; Xiuwu H; Juzhong G; Juanjun X; Zhiyou H
    Transplant Proc; 2000 Nov; 32(7):1930-1. PubMed ID: 11120006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytomegalovirus-associated haemophagocytic syndrome in a kidney transplant patient].
    Bea Granell S; Beneyto Castello I; Ramos Escorihuela D; Sánchez Plumed J; Sánchez Pérez P; Hernández-Jaras J; Rivas S
    Nefrologia; 2011; 31(2):236-8. PubMed ID: 21461026
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients.
    Campbell AL; Herold BC
    Pediatr Transplant; 2004 Dec; 8(6):619-27. PubMed ID: 15598337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience.
    Babel N; Gabdrakhmanova L; Juergensen JS; Eibl N; Hoerstrup J; Hammer M; Rosenberger C; Hoeflich C; Frei U; Rohde F; Volk HD; Reinke P
    Transplantation; 2004 Jul; 78(2):283-5. PubMed ID: 15280691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.